Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s): ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

TSX:ATE - Post by User

Antibe Therapeutics Inc(Pre-Merger) > SCARY

<< Previous

Bullboard Posts

Next >>

Comment by TriumphSpitSixon Jun 22, 2020 11:44pm

233 Views

Post# 31179365

RE:RE:RE:RE:SCARY

Lol, I knew it... A non-native speaker mangling the lingo. Foreign operative outted.

AlbertaGuy9 wrote: Another con-artist spotted -Claiming he invested since 2.5 years but he opened SH account today. Fact- He bought today at 43 cents to flip at 45 cents to make some burger money. He is now upset to see this garbage still stuck at 43 cents. Do not worry keep adding to average down.

Howsitgoing2020 wrote:
You said you just took your first position June 10th. Shows how committed you are, have you ever even invested before this?

Don't listen to this garbage. I suggest everyone do your own DD unlike this joker. As much I'm frustrated with where we are right now after 2.5 years invested I stay committed for the science, and hopeful that management will catch up to it.